News | November 03, 2023
Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The delegation's visit covered a wide range of topics
Subscribe To Our Newsletter & Stay Updated
